The Alcohol Mirror That Explains Food Noise

Drawn from public community discussion and labeled as community-sourced observation throughout, this is what people who use GLP-1 receptor agonists report about food noise, craving, dopamine, and the alcohol mirror. Shared experience for research use only, and it is not medical advice.

I · The voice that counts the calories

The most useful thing the retatrutide community has produced on weight loss psychology is a name for a phenomenon most chronic dieters recognize instantly. Food noise is the pressure to eat that runs underneath hunger, the background voice that keeps a running tally of edible things in reach, and people who have lived with it describe it as constant the way a radio station left on low is constant. One prolific community educator, a knowledgeable amateur who acts as the misinformation cop of his corner of the retatrutide subreddit, tells a story that became the community’s shorthand for the difference between restraint and relief, because it happened the morning after his first injection. ¹

“The last Friday of September 2025 I took my first shot of reta. That all went extinct for me the next morning.” [anecdotal]

Community member, r/retatrutide corpus, 2025

The rest of that story is why people save the thread, since he describes the same bag of tortilla chips he would normally maul: “There were the damn tortilla chips that I’d normally maul. I ate six. It wasn’t an act of willpower… I only wanted six. I don’t know that I had ever experienced that before.” [anecdotal]¹ He had dieted before, which is why he insists this was something else, and the distinction matters because the community’s vocabulary for these drugs rests on it. The educator’s own explanation goes to the subconscious: “The subconscious brain is very good at getting the amount of calories it wants!” [anecdotal]² Hunger, in this framing, is the body’s signal that it needs fuel, whereas food noise is the reward system’s commentary on edible things in reach, and the two run on different circuits that a GLP-1 receptor agonist touches in different ways.

Hunger comes and goes with meals and deficits, but food noise is ambient, since it can survive a calorie deficit intact and can disappear while hunger stays fully functional, and both observations show up constantly in the community reports. ² The practical takeaway from the community’s own language is that naming the phenomenon is the first management step, because people who can say “that is food noise, and it is separate from hunger” stop treating the craving as a character flaw and start treating it as a signal with a dial on it.

II · A drug that works on the brain

The older explanation for how GLP-1 receptor agonists cause weight loss, the one your doctor may still reach for, is that they slow the stomach and make you feel full, and the community educator is blunt that this is a side effect rather than the mechanism. ³ The current theory, in his words, is that “GLP-1s achieve almost their entire weight loss effect via CNS effects at the brain,” and he describes them as a drug that fixes the brain so it works correctly, with the corollary that when the drug stops, the brain starts working incorrectly again. ³ That reading sits on a specific trial record, since the phase 2 obesity trial of retatrutide, reported by Jastreboff and colleagues in the New England Journal of Medicine in 2023, produced the results that made the compound famous, and the community’s mechanistic arguments lean on the central nervous system. ⁴

The community’s favorite thought experiment for this is a receptor knockout: “Knock out the peripheral GLP-1 receptors and the drug still causes weight loss almost as usual. Knock out the central GLP-1 receptors and it barely does anything.” [anecdotal]³ The community does not claim to have run that experiment, and the statement is a compressed version of a research conversation rather than a published result, but it captures the direction of the evidence as the educator reads it, which is that appetite and reward effects in the central nervous system do most of the work. ³ Gastric emptying and nausea still happen, but the community has watched the field walk the mechanism back from the gut to the brain, and the same shift shows up in users’ own experience, with the SURMOUNT-1 trial of tirzepatide behind much of that reasoning. ⁵

If the effect lives in the brain, then the psychology of these drugs is the mechanism itself, which is why the community’s reports about cravings and dopamine read like field notes on the drug’s main event. The open question is why the brain changes feel so specific, since some users report the disappearance of food pressure while other pressures remain untouched. ⁵ The practical takeaway is that users who understand the CNS framing stop judging the drug by how full it makes them feel, because fullness was beside the point.

III · The cravings that push through

A minority of users on retatrutide report cravings that push through the suppression, and the educator describes the phenomenon plainly: “One common and often frustrating side effect many people report with reta is food cravings, that they basically have strong cravings for certain types of food.” [anecdotal]⁶ The cravings have a distinctive shape, since they are often sugary and they arrive on top of a working appetite suppression, and they rarely prevent weight loss, which makes them more of a puzzle than a problem. ⁶ The educator’s hypothesis is that the compound’s glucagon arm does something to a metabolic hormone called FGF21, because trial data show dramatic FGF21 changes that he describes as “superficially similar to changes that happen during pregnancy.” ⁶ His fullest version of the argument runs: “during reta treatment we see drops exceeding 50%…You know when else we see 50% drops in FGF21 in humans? The first and second trimester of pregnancy. There’s your cravings.” [anecdotal]⁶

The pregnancy comparison is doing a lot of work in that sentence, since pregnancy is one of the few familiar human states where cravings and aversions coexist with a body that is clearly metabolically fine, a natural mirror for craving without pathology. ⁷ The reason this stays in the theory column is that the direction of the FGF21 change is contested, since the educator notes that the preclinical research and the trial data do not exactly agree on the direction, and the packet flag records that FGF21-preference research is real in mice and humans while the reta-specific link stays a community theory. ⁷ The honest summary is that something about retatrutide changes FGF21 dramatically, that FGF21 is tied to food preference in animal and human research, and that the causal chain stays unsettled.

The management advice from this corner of the community is refreshingly low-tech, since the same users who theorize about FGF21 recommend redirecting the craving to fruit or protein rather than fighting it head on, and they note it rarely derails the overall loss. ⁶ The takeaway is that a craving surviving suppression is a data point, a metabolic quirk worth naming rather than a sign the drug has stopped working, which saves a lot of people from panic-titrating at the first sugar craving.

IV · Injectable willpower

The phrase the community reaches for most often is injectable willpower, and the educator states the version quoted back to him constantly: “GLP-1s in general are basically injectable willpower.” [anecdotal]¹⁰ His own expansion of that idea is more precise than the slogan, since he describes what the drugs do as dulling the dopamine reward circuitry: “They dull the dopamine reward circuitry… They won’t stop you from doing the thing but they take away a lot of the cognitive reinforcement.” [anecdotal]⁸ That sentence contains the whole paradox, because the behavior is still available and the compulsion is still there, but the reinforcement loop that made it self-sustaining has been turned down, which feels like the difference between swimming upstream and floating. ⁸

The same dynamic shows up across the addictive spectrum, since one user’s clinical summary of the mechanism runs: “Yeah, GLP-1s seem to rework the brain’s dopamine reward signaling and we see that play out as a reduction in all sorts of addictive behaviors. Alcohol, cigarettes, and even hard drugs too. It’s likely that this is a big part of how these drugs cause weight loss too.” [anecdotal]⁹ Another user describes the daily tasks of eating well suddenly becoming easy, and the full account is worth quoting because the repetition is the point: “I started a GLP-1 and suddenly it was easy to track all of my calories and macros, suddenly it was easy to eat home-cooked food, suddenly it was easy to say no to junk food, suddenly it was easy to go to the gym five days a week.” [anecdotal]¹⁰ The educator’s own framing captures the same thing from the inside: “There’s a reason people describe these drugs as injectable willpower but even that doesn’t fully capture the dynamic: what previously required immense willpower and commitment suddenly became easy.” [anecdotal]¹⁰

The nuance that keeps this from being a fairy tale is that dulled reinforcement cuts both ways, since the circuitry that made chips rewarding is the circuitry that makes a lot of life rewarding, and the community’s reports split on what happens to the healthy pleasures. That split belongs in the dopamine picture too, since it is the same dial turned to different settings for different people. ¹⁴ For most of these users the missing ingredient was a quiet reward system rather than willpower, because they had exercised willpower for years, and that is what the drug supplies while it is on board. ¹⁰

V · The alcohol mirror

The most personal thread in the corpus comes from the educator himself, who is open about being a former alcoholic and uses his drinking history as the analogy for food addiction, including in his longest comment, a personal essay on addiction versus willpower. ¹¹ The mirror he describes is explicit: “Prior to starting a GLP-1 I never mentally connected my dysfunctional relationship with food to my alcoholism but in retrospect I learned that they mirrored one another.” [anecdotal]¹¹

“To paraphrase this in terms of other addictions, it was like I was able to have two drinks on Friday night and be happy the rest of the week.” [anecdotal]

Community member, r/retatrutide corpus, 2025

That last line is the one the community quotes back often, because it compresses the drug’s promise into a single social situation: the Friday night drinks still happen, and nothing after them falls apart. ¹¹ The same user, reflecting on his years of failed moderation, draws the parallel to food in a way that diet advice rarely managed: “I remember for years before I gave up drinking I tried again and again and again to moderate my behavior. All I had to do was drink less, it was that simple.” [anecdotal]¹¹ That sentence has the same structure as most food noise complaints in the corpus, since the obvious solution to a drinking problem is to drink less and the obvious solution to an eating problem is to eat less, and the mystery of both conditions is why the obvious solution fails so reliably.

The industry appears to be following the same mirror, since Eli Lilly has a GLP-1 program aimed at the addiction side of the equation:

“Eli Lilly has a drug in phase 3 clinical trials right now called brenipatide. It’s somewhat similar to tirzepatide but they’re specifically studying it as a neuro drug with trials into things like alcohol and cigarette use as well as bipolar disorder.”

Community educator, r/retatrutide corpus, 2025

The educator states that as a plain fact of the trial landscape, but its significance is that the reward system users discovered through food noise is now an official research target for alcohol and cigarette use. ¹²

The takeaway from the alcohol mirror is that the addiction framing gives users a vocabulary for what the drug is doing that the weight loss framing could not manage, because people do not talk about cheat days for alcohol; they talk about relapse, and that word fits the food experience better than most people are comfortable admitting.

VI · The anhedonia nuance

The same reward circuitry that quiets food noise can, for a subset of users, quiet too much, and the community has a word for the experience: anhedonia, the clinical term for reduced pleasure in things that used to feel good. ¹⁴ The educator’s framework is honest about the double edge, since he describes GLP-1s as rewiring and dulling the dopamine reward system, which suppresses the urges for alcohol, cocaine, cigarettes, and shopping while also, for some people, reaching into the healthy pleasures, from music to the social rituals around food. ¹⁴ One user in the corpus puts the flattened version of the experience plainly: “Food still tasted good but I didn’t really care that it did.” [anecdotal]¹⁴ That sentence sounds like relief and like loss depending on where you sit, which is why the community treats the anhedonia reports as a nuance rather than a verdict.

The community’s most useful intervention is the confound, because the educator points out that a calorie deficit flattens reward on its own: “Calorie deficits will do that too.” [anecdotal]⁸ Weight loss itself dulls the dopamine economy, since a body in a deficit runs lean on the same circuitry, so some of the reported flattening is the diet and some is the drug, and the community has no clean data to split the two. ⁸ His own prediction is that the flattening fades like other perceived effects, since he expects people on long-term maintenance to become more interested in alcohol and cannabis again, and he summarizes the trajectory with the phrase “long term maintenance mirrors baseline.” ¹⁴

The open question is whether the anhedonia is a tolerable trade for people who spent decades fighting food noise, since the answer depends on how much healthy pleasure gets caught in the dulling, which varies person to person and dose to dose. ¹⁴ The practical takeaway is that users who notice the flattening reaching into things they love have a vocabulary for it now, and the community’s advice is to name it and watch it, then adjust the dose with whoever prescribes for them, since a dial turned down is still a dial.

VII · Bad habits reemerge at maintenance

The other side of the anhedonia coin is what happens when the dose settles into maintenance, and the community’s reports are remarkably consistent: “Everybody who’s on maintenance with these drugs complains that they notice a lot of ‘bad habits’ reemerge.” [anecdotal]¹⁴ The educator is explicit that the dulling is temporary, and the reemergence is the expected shape of a drug that works while it is on board. ¹⁴ Maintenance has a specific technical meaning here, since the same users who titrated up through the weight loss phase find that “all doses eventually become maintenance doses once you’ve lost enough weight,” and the experience of a maintenance dose is almost anticlimactic: “You’ll just feel normal because your appetite is normal.” [anecdotal]¹⁵

The reemergence reports take two forms, since some users describe the return of the old background noise at a low volume and others describe specific behaviors, like the drinks or the shopping urges, creeping back as the deficit closes. ¹⁴ The educator’s blunt summary of the permanence question is that “most people will need to find a long-term maintenance dose of the drug or they’ll get fat again,” and his defense of lifelong use is framed as the core promise: “The real magic trick is that you can keep taking them and keep that weight off forever.” [anecdotal]¹⁵ The same corpus notes that most people who discontinue, including people on retatrutide, will regain most or all of the weight they lost, and it cites the 2025 Nature work on obesogenic memory as the reason the body keeps the old set point on file. ¹⁵ One user’s image for the whole arc is the white-knuckle diet, since rebound hunger after stopping sits above baseline, at the level you would feel after “white-knuckling your way through dieting 30% of your weight off,” which is a hunger that has been waiting. ¹⁵

The synthesis the community reaches is that the drug is a management tool with an ongoing job, and the bad habits reemerging at maintenance are the job description rather than a personal failure, which reframes keeping the weight off from a test of character to a question of logistics. ¹⁵ The open question the corpus does not pretend to answer is whether anything else can do that job, since the maintenance literature the community cites suggests the alternative is the white-knuckle version, and the users who have lived both versions mostly choose the syringe. This article is community-sourced, not medical advice; the compounds discussed are for research use only, and anyone considering them should be working with a clinician who has the full picture.